Stock Events

Stock Events

TAO Synergies 

$5.7
17
-$0.03-0.52% Thursday 19:59

Statistics

Day High
6
Day Low
5.35
52W High
11.98
52W Low
1.84
Volume
110,761
Avg. Volume
166,168
Mkt Cap
40.64M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-2.06
-1.73
-1.39
-1.06
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-27.12MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TAOX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Biogen focuses on neurodegenerative diseases, directly competing with Synaptogenix's Alzheimer's and neurological disorder treatments.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly has a strong pipeline in Alzheimer's disease treatments, making it a direct competitor in the neurodegenerative space.
Annovis Bio
ANVS
Mkt Cap48.93M
Annovis Bio is engaged in developing therapies for Alzheimer's and Parkinson's diseases, directly competing with Synaptogenix.
AC Immune SA
ACIU
Mkt Cap340.03M
AC Immune SA specializes in neurodegenerative diseases, including Alzheimer's, competing in the same therapeutic area as Synaptogenix.
Anavex Life Sciences
AVXL
Mkt Cap684.57M
Anavex Life Sciences Corp. focuses on developing drugs for Alzheimer's disease, directly competing in the same field.
Athira Pharma Inc
ATHA
Mkt Cap16.39M
Athira Pharma focuses on regenerating neural health, including Alzheimer's disease treatments, competing in the same space.
Arbutus Biopharma
ABUS
Mkt Cap906.73M
Arbutus Biopharma Corporation, though primarily focused on antiviral drugs, has ventured into neurodegenerative diseases, positioning it as a potential competitor.

About

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
Show more...
CEO
Mr. Joshua N. Silverman
Employees
4
Country
US
ISIN
US87167T3005

Listings

XNAS
US
TAOX
BATS
US
SNPX
BOATS
BOATS
TAOX.BOATS

0 Comments

Share your thoughts

FAQ

What is TAO Synergies stock price today?▼
The current price of TAOX is $5.7 USD — it has decreased by -0.52% in the past 24 hours. Watch TAO Synergies stock price performance more closely on the chart.
What is TAO Synergies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange TAO Synergies stocks are traded under the ticker TAOX.
Is TAO Synergies stock price growing?▼
TAOX stock has risen by +9.2% compared to the previous week, the month change is a +37.68% rise, over the last year TAO Synergies has showed a +151.1% increase.
What is TAO Synergies market cap?▼
Today TAO Synergies has the market capitalization of 40.64M
When is the next TAO Synergies earnings date?▼
TAO Synergies is going to release the next earnings report on June 03, 2026.
What is TAO Synergies revenue for the last year?▼
TAO Synergies revenue for the last year amounts to 0 USD.
What is TAO Synergies net income for the last year?▼
TAOX net income for the last year is -27.12M USD.
How many employees does TAO Synergies have?▼
As of April 03, 2026, the company has 4 employees.
In which sector is TAO Synergies located?▼
TAO Synergies operates in the Information Technology sector.
When did TAO Synergies complete a stock split?▼
The last stock split for TAO Synergies was on April 05, 2024 with a ratio of 1:25.
Where is TAO Synergies headquartered?▼
TAO Synergies is headquartered in New York, US.